Metabolomic approaches to phenotype characterization and applications to complex diseases

被引:67
作者
Oresic, Matej
Vidal-Puig, Antonio
Hanninen, Virve
机构
[1] VTT Tech Res Ctr Finland, FIN-02044 Espoo, Finland
[2] Zora Biosci Ltd, FIN-02044 Espoo, Finland
[3] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem & Metab Med, Cambridge CB2 2QR, England
[4] Orion Pharma, Clin Res & Dev, FIN-02101 Espoo, Finland
基金
英国医学研究理事会;
关键词
biomarker; critical path research; metabolomics; pharmacology; quantitative disease model; systems biology; toxicology; translational path research;
D O I
10.1586/14737159.6.4.575
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Metabolites are the key regulators of systems homeostasis. As such, concentration changes of specific groups of metabolites may reflect systemic responses to environmental, therapeutic or genetic interventions. Thus, the study of metabolites is a powerful tool for the characterization of complex phenotypes as well as for the development of biomarkers for specific physiological responses. Therefore, metabolomics is a valuable platform for studies of complex diseases and the development of new therapies, both in nonclinical disease model characterization and clinical settings.
引用
收藏
页码:575 / 585
页数:11
相关论文
共 67 条
[1]   Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice [J].
Almind, K ;
Kahn, CR .
DIABETES, 2004, 53 (12) :3274-3285
[2]   LOOKING TO THE FUTURE IN PSYCHIATRIC EPIDEMIOLOGY [J].
ANTHONY, JC ;
EATON, WW ;
HENDERSON, AS .
EPIDEMIOLOGIC REVIEWS, 1995, 17 (01) :240-242
[3]  
Ardrey R.E., 2003, LIQUID CHROMATOGRAPH
[4]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[5]   Partial least squares for discrimination [J].
Barker, M ;
Rayens, W .
JOURNAL OF CHEMOMETRICS, 2003, 17 (03) :166-173
[6]   Large-scale human metabolomics studies: A strategy for data (pre-) processing and validation [J].
Bijlsma, S ;
Bobeldijk, L ;
Verheij, ER ;
Ramaker, R ;
Kochhar, S ;
Macdonald, IA ;
van Ommen, B ;
Smilde, AK .
ANALYTICAL CHEMISTRY, 2006, 78 (02) :567-574
[7]   The Unified Medical Language System (UMLS): integrating biomedical terminology [J].
Bodenreider, O .
NUCLEIC ACIDS RESEARCH, 2004, 32 :D267-D270
[8]   NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition [J].
Bollard, ME ;
Stanley, EG ;
Lindon, JC ;
Nicholson, JK ;
Holmes, E .
NMR IN BIOMEDICINE, 2005, 18 (03) :143-162
[9]   Minimum information about a microarray experiment (MIAME) - toward standards for microarray data [J].
Brazma, A ;
Hingamp, P ;
Quackenbush, J ;
Sherlock, G ;
Spellman, P ;
Stoeckert, C ;
Aach, J ;
Ansorge, W ;
Ball, CA ;
Causton, HC ;
Gaasterland, T ;
Glenisson, P ;
Holstege, FCP ;
Kim, IF ;
Markowitz, V ;
Matese, JC ;
Parkinson, H ;
Robinson, A ;
Sarkans, U ;
Schulze-Kremer, S ;
Stewart, J ;
Taylor, R ;
Vilo, J ;
Vingron, M .
NATURE GENETICS, 2001, 29 (04) :365-371
[10]  
Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802